RecruitingPhase 2NCT07208799

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Comparison of Effectiveness of Submucosal Dexamethasone and Methylprednisolone in Management of Postoperative Sequelae in Mandibular Parasymphysis Fractures


Sponsor

Nishtar Medical University

Enrollment

72 participants

Start Date

Jan 3, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria4

  • Patients aged 18 to 40.
  • Both Gender.
  • Fracture less than a week old.
  • Isolated mandibular parasymphysis fractures.

Exclusion Criteria10

  • \. Immunocompromised patients (due to increased risk of infection and complications).
  • \. Patients experiencing acute pain from conditions such as pulpitis, abscesses, or other acute infections (to ensure that acute pain does not confound the study results).
  • \. Patients reporting hypersensitivity to steroids (to avoid adverse reactions).
  • \. Patients taking or requiring prophylactic antibiotics or anti-inflammatory drugs before surgery (to prevent confounding effects on study outcomes).
  • \. Patients with a history of systemic steroid administration for 15 days (as this could affect the study's outcomes).
  • \. Patients with chronic pain problems or mental disorders (to maintain consistency in response to treatment).
  • \. Patients with comminuted fractures (to maintain consistency in fracture type).
  • \. Pregnant or lactating women (to avoid potential risks to the fetus and nursing infant).
  • \. Smokers who smoke at least 10 cigarettes per day for 2 years (to minimize the impact of smoking on healing and recovery).
  • ria:

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone

single dose of dexamethasone 8 mg (2 mL) administered submucosally at the surgical site 30 minutes before incision.

DRUGMethylprednisolone (Corticosteroid)

a single dose of methylprednisolone 40 mg (2 mL) will be administered submucosally at the surgical site 30 minutes before incision.


Locations(1)

Nishtar Institute of Dentistry Multan

Multan, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07208799


Related Trials